Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Japanese researchers present novel GPR119 receptor agonists

Sep. 20, 2012

Researchers present results from taliglucerase alfa trials

Sep. 20, 2012

SBC-102 demonstrates safety and clinical activity in patients with LAL deficiency

Sep. 19, 2012

VIVUS launches once-daily Qsymia in the U.S. for weight management

Sep. 19, 2012

New ghrelin receptor antagonists disclosed by Helsinn Healthcare

Sep. 19, 2012

Biodel advances with phase II insulin study

Sep. 17, 2012

Phase III study of Androxal enrolls first patients

Sep. 14, 2012

First phase finishes in endometrial regenerative cell therapy project

Sep. 14, 2012

Zealand Pharma's dual-acting candidate enters phase I trial

Sep. 14, 2012

Galapagos presents promising in vivo results for GLPG-0492

Sep. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...